Halozyme Therapeutics
HALO
#2006
Rank
S$10.38 B
Marketcap
$81.99
Share price
1.04%
Change (1 day)
53.33%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): $2.38

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is $2.27. In 2022 the company made an earnings per share (EPS) of $1.93 a decrease over its 2021 EPS that were of $3.71.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.3823.4%
2022$1.93-48.07%
2021$3.71196.88%
2020$1.25-292%
2019-$0.65-9.09%
2018-$0.72-237.5%
2017$0.52-149.38%
2016-$1.06211.54%
2015-$0.34-52.73%
2014-$0.72-24.66%
2013-$0.9548.98%
2012-$0.64145%
2011-$0.26-64.29%
2010-$0.73-17.65%
2009-$0.899.68%
2008-$0.8193.75%
2007-$0.4233.33%
2006-$0.31-4%
2005-$0.33-3.85%
2004-$0.34-13.33%
2003-$0.3983.59%
2002-$0.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.25-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.07 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.67 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.42 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.14 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
$18.35 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA